( en | de | ru )

 

Disambiguation of "Westermann, Frank"

Author of the publication

copydeleteadd this publication to your clipboard
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

, , , , , , , , , , and . Nat Med, 7 (6): 673--679 (June 2001)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Frank Westermann

Bernhard Westermann

H Westermann

H Westermann

Richard Westermann

 

Other publications of authors with the same name

Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , and 4 other author(s). J Clin Oncol, 24 (31): 5070--5078 (November 2006)High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status., , , , , , , , , and 4 other author(s). Clin Cancer Res, 13 (16): 4695--4703 (August 2007)Factor price equalization?, and . CESifo working paper series Univ., Center for Economic Studies, Munich, (2001)Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, , , , , , , , , and 1 other author(s). Nat Med, 7 (6): 673--679 (June 2001)SeptemBear, , and . Münchener wirtschaftswissenschaftliche Beiträge Univ., Volkswirtschaftl. Fak., München, (2000)Equity price dynamics before and after the introduction of the Euro, and . CESifo working papers Univ., Center for Economic Studies, Munich, (2001)Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes., , , , , and . BMC Cancer, (2007)Decomposing the effects of financial liberalization: Crises vs. growth, , and . Journal of Banking & Finance, 30 (12): 3331--3348 (December 2006)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , and 1 other author(s). Cancer Lett, 250 (2): 250--267 (June 2007)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , and 8 other author(s). Clin Cancer Res, 17 (15): 5082--5092 (August 2011)